{
    "title": "Shingles jab sales record a shot in the arm for GSK: UK pharma giant predicts strong growth for 2023",
    "url": "https://www.dailymail.co.uk/money/markets/article-11702315/Record-shingles-jab-sales-record-shot-arm-GSK.html",
    "date": "2023-02-01",
    "keywords": [
        "cent",
        "gsk",
        "growth",
        "dame",
        "year",
        "share",
        "investment",
        "fund",
        "boss",
        "emma",
        "walmsley",
        "record",
        "vaccine",
        "trade",
        "profit",
        "money",
        "platform",
        "account",
        "fee",
        "shot",
        "arm",
        "pharma",
        "giant",
        "covid",
        "treatmentsfor",
        "yearonyear",
        "demand",
        "hiv",
        "forecast",
        "step",
        "change",
        "performance",
        "momentum",
        "confidence",
        "consumer",
        "healthcare",
        "business",
        "haleon",
        "maker",
        "toothpaste",
        "firm",
        "activist",
        "ability",
        "wire",
        "act",
        "time",
        "chief",
        "alison",
        "inflation",
        "reserve",
        "facebook",
        "owner",
        "article",
        "diy",
        "drug",
        "approval",
        "virus",
        "coldlike",
        "illness",
        "jab",
        "market",
        "billionswalmsley",
        "life",
        "point",
        "uk",
        "country",
        "capital",
        "risk",
        "isa",
        "month",
        "community",
        "model",
        "affiliate",
        "product",
        "commission",
        "editorial",
        "independence",
        "investing"
    ],
    "category": [
        "money",
        "markets"
    ]
}